The Study of Ingavirin® as the Drug for Prophylaxis and Treatment of Postvaccinal Reactions on Teovac in Animal Models
The experiment on guinea pigs shows that Ingavirin, when administered orally in a single dose of 15 mg/kg on the 4 th day after vaccination with TEOVac, reduces accumulation of vaccine virus in organs and tissues of animals without affecting the immunogenicity of the vaccine. This efficacy is less p...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-05-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/114 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849248696897634304 |
|---|---|
| author | N. K. Chernikova S. V. Borisevich A. L. Khmelev S. A. Nimirskaya S. A. Melnikov |
| author_facet | N. K. Chernikova S. V. Borisevich A. L. Khmelev S. A. Nimirskaya S. A. Melnikov |
| author_sort | N. K. Chernikova |
| collection | DOAJ |
| description | The experiment on guinea pigs shows that Ingavirin, when administered orally in a single dose of 15 mg/kg on the 4 th day after vaccination with TEOVac, reduces accumulation of vaccine virus in organs and tissues of animals without affecting the immunogenicity of the vaccine. This efficacy is less pronounced when it is used together with TEOVac. When administered three times orally on days 6, 7, and 8 after immunization, Ingavirin reduces the level of vaccine virus in the blood, liver, and oral mucosa by a factor of 2 or more. Ingavirin is almost as effective as Arbidol, but less effective than Ridostin. These data indirectly indicate the possibility of using ingavirin along with ridostin to prevent post-vaccination reactions during immunization with TEOVac, and also give grounds to consider ridostin, ingavirin, and arbidol as a means of treating post-vaccination reactions. |
| format | Article |
| id | doaj-art-c3dae5d1df2b4fbc94a3498c03de9f5a |
| institution | Kabale University |
| issn | 0235-2990 |
| language | Russian |
| publishDate | 2020-05-01 |
| publisher | LLC "Publishing House OKI" |
| record_format | Article |
| series | Антибиотики и Химиотерапия |
| spelling | doaj-art-c3dae5d1df2b4fbc94a3498c03de9f5a2025-08-20T03:57:47ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902020-05-01641-291310.24411/0235W2990W2019W10002113The Study of Ingavirin® as the Drug for Prophylaxis and Treatment of Postvaccinal Reactions on Teovac in Animal ModelsN. K. Chernikova0S. V. Borisevich1A. L. Khmelev2S. A. Nimirskaya3S. A. Melnikov4The Federative State Central Research Institute No. 48 of the Ministry of Defense of RussiaThe Federative State Central Research Institute No. 48 of the Ministry of Defense of RussiaThe Federative State Central Research Institute No. 48 of the Ministry of Defense of RussiaThe Federative State Central Research Institute No. 48 of the Ministry of Defense of RussiaThe Federative State Central Research Institute No. 48 of the Ministry of Defense of RussiaThe experiment on guinea pigs shows that Ingavirin, when administered orally in a single dose of 15 mg/kg on the 4 th day after vaccination with TEOVac, reduces accumulation of vaccine virus in organs and tissues of animals without affecting the immunogenicity of the vaccine. This efficacy is less pronounced when it is used together with TEOVac. When administered three times orally on days 6, 7, and 8 after immunization, Ingavirin reduces the level of vaccine virus in the blood, liver, and oral mucosa by a factor of 2 or more. Ingavirin is almost as effective as Arbidol, but less effective than Ridostin. These data indirectly indicate the possibility of using ingavirin along with ridostin to prevent post-vaccination reactions during immunization with TEOVac, and also give grounds to consider ridostin, ingavirin, and arbidol as a means of treating post-vaccination reactions.https://www.antibiotics-chemotherapy.ru/jour/article/view/114ingavirinarbidolridostinimmunizationsmall-pox vaccineteovacpostvaccinal reactionprophylaxistreatment |
| spellingShingle | N. K. Chernikova S. V. Borisevich A. L. Khmelev S. A. Nimirskaya S. A. Melnikov The Study of Ingavirin® as the Drug for Prophylaxis and Treatment of Postvaccinal Reactions on Teovac in Animal Models Антибиотики и Химиотерапия ingavirin arbidol ridostin immunization small-pox vaccine teovac postvaccinal reaction prophylaxis treatment |
| title | The Study of Ingavirin® as the Drug for Prophylaxis and Treatment of Postvaccinal Reactions on Teovac in Animal Models |
| title_full | The Study of Ingavirin® as the Drug for Prophylaxis and Treatment of Postvaccinal Reactions on Teovac in Animal Models |
| title_fullStr | The Study of Ingavirin® as the Drug for Prophylaxis and Treatment of Postvaccinal Reactions on Teovac in Animal Models |
| title_full_unstemmed | The Study of Ingavirin® as the Drug for Prophylaxis and Treatment of Postvaccinal Reactions on Teovac in Animal Models |
| title_short | The Study of Ingavirin® as the Drug for Prophylaxis and Treatment of Postvaccinal Reactions on Teovac in Animal Models |
| title_sort | study of ingavirin r as the drug for prophylaxis and treatment of postvaccinal reactions on teovac in animal models |
| topic | ingavirin arbidol ridostin immunization small-pox vaccine teovac postvaccinal reaction prophylaxis treatment |
| url | https://www.antibiotics-chemotherapy.ru/jour/article/view/114 |
| work_keys_str_mv | AT nkchernikova thestudyofingavirinasthedrugforprophylaxisandtreatmentofpostvaccinalreactionsonteovacinanimalmodels AT svborisevich thestudyofingavirinasthedrugforprophylaxisandtreatmentofpostvaccinalreactionsonteovacinanimalmodels AT alkhmelev thestudyofingavirinasthedrugforprophylaxisandtreatmentofpostvaccinalreactionsonteovacinanimalmodels AT sanimirskaya thestudyofingavirinasthedrugforprophylaxisandtreatmentofpostvaccinalreactionsonteovacinanimalmodels AT samelnikov thestudyofingavirinasthedrugforprophylaxisandtreatmentofpostvaccinalreactionsonteovacinanimalmodels AT nkchernikova studyofingavirinasthedrugforprophylaxisandtreatmentofpostvaccinalreactionsonteovacinanimalmodels AT svborisevich studyofingavirinasthedrugforprophylaxisandtreatmentofpostvaccinalreactionsonteovacinanimalmodels AT alkhmelev studyofingavirinasthedrugforprophylaxisandtreatmentofpostvaccinalreactionsonteovacinanimalmodels AT sanimirskaya studyofingavirinasthedrugforprophylaxisandtreatmentofpostvaccinalreactionsonteovacinanimalmodels AT samelnikov studyofingavirinasthedrugforprophylaxisandtreatmentofpostvaccinalreactionsonteovacinanimalmodels |